» Authors » Sara Lee de Menezes

Sara Lee de Menezes

Explore the profile of Sara Lee de Menezes including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 11
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta A, Manuelpillai N, de Menezes S, Prakash S, Kern J
Australas J Dermatol . 2024 Dec; 66(1):45-47. PMID: 39670553
No abstract available.
2.
Gupta A, de Menezes S, Howard M, OKeefe R, Prakash S, Kern J
Skin Appendage Disord . 2024 Oct; 10(5):433-438. PMID: 39386307
Introduction: Subungual acantholytic dyskeratotic acanthoma is a rare benign tumor of epidermal keratinocytes characterized by acantholysis and dyskeratosis. Only 7 other cases have been published in the literature. Case Presentation:...
3.
Gupta A, de Menezes S
Aust J Gen Pract . 2024 Apr; 53(4):203-209. PMID: 38575540
Background: A red rash on the face in an adult patient is a common presentation to general practice in Australia. Rashes on the face significantly affect quality of life because...
4.
Gupta A, de Menezes S
Aust J Gen Pract . 2023 Dec; 52(12):856-860. PMID: 38049134
Background: Older patients with a red scaly eruption often present first to a primary care practitioner. A thorough clinical assessment can help delineate between common causes and assist the clinician...
5.
Mazzoni D, Tee H, de Menezes S, Graudins L, Johnson D, Newnham E, et al.
J Clin Pharmacol . 2020 Jul; 61(1):25-31. PMID: 32648298
Severe drug hypersensitivity reactions (DHRs) are often encountered by health care professionals (HCPs). We evaluated knowledge of doctors and pharmacists in the assessment and management of severe DHRs using a...
6.
de Menezes S, Wolfe R, Kelly J, Farrugia H, Mar V
Australas J Dermatol . 2019 Dec; 61(2):134-139. PMID: 31869446
Background/objective: Partial biopsies are sometimes used for melanoma diagnosis with anticipated time and cost savings compared to excisional biopsy. However, their impact on subsequent melanoma management is unknown. Determine factors...
7.
Aung A, Tang M, Adler N, de Menezes S, Goh M, Tee H, et al.
J Clin Pharmacol . 2018 May; 58(10):1332-1339. PMID: 29733431
We describe adverse drug reaction (ADR) reporting characteristics and factors contributing to length of time to report by healthcare professionals. This is a retrospective study of voluntary reports to an...